MedMira Inc
XTSX:MIR

Watchlist Manager
MedMira Inc Logo
MedMira Inc
XTSX:MIR
Watchlist
Price: 0.085 CAD Market Closed
Market Cap: 61.3m CAD
Have any thoughts about
MedMira Inc?
Write Note

Intrinsic Value

MIR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MIR stock under the Base Case scenario is 0.002 CAD. Compared to the current market price of 0.085 CAD, MedMira Inc is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MIR Intrinsic Value
0.002 CAD
Overvaluation 97%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
MedMira Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MIR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MIR?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about MedMira Inc

Provide an overview of the primary business activities
of MedMira Inc.

What unique competitive advantages
does MedMira Inc hold over its rivals?

What risks and challenges
does MedMira Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MedMira Inc.

Provide P/S
for MedMira Inc.

Provide P/E
for MedMira Inc.

Provide P/OCF
for MedMira Inc.

Provide P/FCFE
for MedMira Inc.

Provide P/B
for MedMira Inc.

Provide EV/S
for MedMira Inc.

Provide EV/GP
for MedMira Inc.

Provide EV/EBITDA
for MedMira Inc.

Provide EV/EBIT
for MedMira Inc.

Provide EV/OCF
for MedMira Inc.

Provide EV/FCFF
for MedMira Inc.

Provide EV/IC
for MedMira Inc.

What are the Revenue projections
for MedMira Inc?

How accurate were the past Revenue estimates
for MedMira Inc?

What are the Net Income projections
for MedMira Inc?

How accurate were the past Net Income estimates
for MedMira Inc?

What are the EPS projections
for MedMira Inc?

How accurate were the past EPS estimates
for MedMira Inc?

What are the EBIT projections
for MedMira Inc?

How accurate were the past EBIT estimates
for MedMira Inc?

Compare the revenue forecasts
for MedMira Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MedMira Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MedMira Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of MedMira Inc compared to its peers.

Compare the P/E ratios
of MedMira Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing MedMira Inc with its peers.

Analyze the financial leverage
of MedMira Inc compared to its main competitors.

Show all profitability ratios
for MedMira Inc.

Provide ROE
for MedMira Inc.

Provide ROA
for MedMira Inc.

Provide ROIC
for MedMira Inc.

Provide ROCE
for MedMira Inc.

Provide Gross Margin
for MedMira Inc.

Provide Operating Margin
for MedMira Inc.

Provide Net Margin
for MedMira Inc.

Provide FCF Margin
for MedMira Inc.

Show all solvency ratios
for MedMira Inc.

Provide D/E Ratio
for MedMira Inc.

Provide D/A Ratio
for MedMira Inc.

Provide Interest Coverage Ratio
for MedMira Inc.

Provide Altman Z-Score Ratio
for MedMira Inc.

Provide Quick Ratio
for MedMira Inc.

Provide Current Ratio
for MedMira Inc.

Provide Cash Ratio
for MedMira Inc.

What is the historical Revenue growth
over the last 5 years for MedMira Inc?

What is the historical Net Income growth
over the last 5 years for MedMira Inc?

What is the current Free Cash Flow
of MedMira Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for MedMira Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MedMira Inc

Current Assets 4.6m
Cash & Short-Term Investments 2.9m
Receivables 1.3m
Other Current Assets 310.1k
Non-Current Assets 1.8m
PP&E 1.8m
Current Liabilities 20.7m
Accounts Payable 2.8m
Accrued Liabilities 3m
Short-Term Debt 6m
Other Current Liabilities 8.9m
Non-Current Liabilities 2.6m
Long-Term Debt 2.6m
Efficiency

Earnings Waterfall
MedMira Inc

Revenue
383.3k CAD
Cost of Revenue
-143.3k CAD
Gross Profit
240k CAD
Operating Expenses
-2.4m CAD
Operating Income
-2.2m CAD
Other Expenses
-957.4k CAD
Net Income
-3.1m CAD

Free Cash Flow Analysis
MedMira Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MIR Profitability Score
Profitability Due Diligence

MedMira Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive ROE
Positive 3-Year Average ROE
27/100
Profitability
Score

MedMira Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

MIR Solvency Score
Solvency Due Diligence

MedMira Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
34/100
Solvency
Score

MedMira Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MIR Price Targets Summary
MedMira Inc

There are no price targets for MIR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MIR?

Click here to dive deeper.

Dividends

MedMira Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MIR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

MedMira Inc Logo
MedMira Inc

Country

Canada

Industry

Health Care

Market Cap

59.6m CAD

Dividend Yield

0%

Description

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.

Contact

NOVA SCOTIA
Halifax
155 Chain Lake Dr.,, Suite 1
+19024501588.0
medmira.com

IPO

1999-12-01

Employees

-

Officers

Co-Founder, CEO, President & Director
Mr. Hermes Chan
Chief Financial Officer
Mr. Markus M. Meile
Director of Scientific & Regulatory Affairs
Dr. Sam Ratnam
Legal Counsel
Stewart McKelvey
Head of Commercialization and Senior Director of Sales & Marketing
Dr. Kevin D. Jones

See Also

Discover More
What is the Intrinsic Value of one MIR stock?

The intrinsic value of one MIR stock under the Base Case scenario is 0.002 CAD.

Is MIR stock undervalued or overvalued?

Compared to the current market price of 0.085 CAD, MedMira Inc is Overvalued by 97%.

Back to Top